Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2025-12-26 @ 3:32 AM
Study NCT ID:
NCT01427920
Status:
COMPLETED
Last Update Posted:
2017-02-24
First Post:
2011-08-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-31
First Submit QC Date:
None
Study First Post Date:
2011-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-07-03
Results First Submit QC Date:
None
Results First Post Date:
2013-09-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-10
Last Update Post Date:
2017-02-24
Last Update Post Date Type:
ACTUAL